Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
February is American Heart Month.
Michelle Routhenstein, a registered dietitian nutritionist and author, joined us live with delicious recipes to help boost your heart health.
Visit...